Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells
Cells · 04.10.2024 · 13 (19) · 1651
DOI: 10.3390/cells13191651 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 04.10.2024. Verfasst von Kavita Prasad und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Kisspeptins, Liver Cirrhosis, Signal Transduction. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: New Jersey Health Foundation (awarded to M.B), NIH (awarded to M.B), NIDDK NIH HHS.
Abstract (Originalsprache)
The peptide hormone kisspeptin attenuates liver steatosis, metabolic dysfunction-associated steatohepatitis (MASH), and fibrosis in mouse models by signaling via the kisspeptin 1 receptor (KISS1R). However, whether kisspeptin impacts fibrogenesis in the human liver is not known. We investigated the impact of a potent kisspeptin analog (KPA) on fibrogenesis using human precision-cut liver slices (hPCLS) from fibrotic livers from male patients, in human hepatic stellate cells (HSCs), LX-2, and in primary mouse HSCs. In hPCLS, 48 h and 72 h of KPA (3 nM, 100 nM) treatment decreased collagen secretion and lowered the expression of fibrogenic and inflammatory markers. Immunohistochemical studies revealed that KISS1R is expressed and localized to HSCs in MASH/fibrotic livers. In HSCs, KPA treatment reduced transforming growth factor b (TGFβ)-the induced expression of fibrogenic and inflammatory markers, in addition to decreasing TGFβ-induced collagen secretion, cell migration, proliferation, and colony formation. Mechanistically, KISS1R signaling downregulated TGFβ signaling by decreasing SMAD2/3 phosphorylation via the activation of protein phosphatases, PP2A, which dephosphorylates SMAD 2/3. This study revealed for the first time that kisspeptin reverses human hepatic fibrogenesis, thus identifying it as a new therapeutic target to treat hepatic fibrosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA.
- Division of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
- Department of Medicine, Columbia University, New York, NY 10032, USA.
- Department of Pathology and Laboratory Medicine, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA.
ORCID-Profile: Shams Gamal Eldin Shams, Kimberly Izarraras, Maryjka B Blaszczyk, Utpal B Pajvani, Scott L Friedman, Moshmi Bhattacharya
Förderung
- New Jersey Health Foundation (awarded to M.B)
- NIH (awarded to M.B)
- NIDDK NIH HHS
- Rutgers NJ Institute for Food Nutrition and Health (awarded to M.B)
- seed grant from the Rutgers NJ Institute for Food Nutrition and Health
Zitieren
APA
Prasad, K., Bhattacharya, D., Shams, S. G. E., Izarraras, K., Hart, T., Mayfield, B., Blaszczyk, M. B., Zhou, Z., Pajvani, U. B., Friedman, S. L., & Bhattacharya, M. (2024). Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells. Cells, 13(19), 1651. https://doi.org/10.3390/cells13191651
Vancouver
Prasad K, Bhattacharya D, Shams SGE, Izarraras K, Hart T, Mayfield B, et al. Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells. Cells. 2024;13(19):1651. doi:10.3390/cells13191651
BibTeX
@article{Prasad2024,
author = {Prasad, Kavita and Bhattacharya, Dipankar and Shams, Shams Gamal Eldin and Izarraras, Kimberly and Hart, Tia and Mayfield, Brent and Blaszczyk, Maryjka B and Zhou, Zhongren and Pajvani, Utpal B and Friedman, Scott L and Bhattacharya, Moshmi},
title = {Kisspeptin Alleviates Human Hepatic Fibrogenesis by Inhibiting TGFβ Signaling in Hepatic Stellate Cells},
journal = {Cells},
year = {2024},
volume = {13},
number = {19},
pages = {1651},
doi = {10.3390/cells13191651}
}
EUVIMED